share

Brd2 CAS NO 1597439-91-2


Unit Price:

CAS No.:1597439-91-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Brd2 CAS NO 1597439-91-2 is a potent and selective small-molecule inhibitor of the Bromodomain-containing protein 2 (BRD2), a key epigenetic reader protein involved in transcriptional regulation. This compound is a critical research tool for investigating the role of BRD2 in cellular processes, disease pathways, and for validating novel therapeutic targets. It is primarily utilized by pharmaceutical R&D teams, academic research institutions, and biotechnology companies focused on oncology, inflammation, and epigenetic drug discovery.

Application

  • Epigenetics Research: Used as a selective chemical probe to study BRD2 function and bromodomain biology in vitro and in vivo.
  • Drug Discovery & Target Validation: Serves as a lead compound or reference standard in high-throughput screening and hit-to-lead optimization campaigns for BRD2 inhibitors.
  • Oncology Research: Investigated for its effects on cancer cell proliferation, apoptosis, and tumor growth in preclinical models, particularly in cancers driven by transcriptional dysregulation.
  • Inflammatory Disease Studies: Applied in research exploring the role of BRD2 in modulating immune responses and inflammatory signaling pathways.
  • Biochemical Assay Development: Employed as a standard inhibitor in developing and calibrating biochemical assays (e.g., TR-FRET, AlphaScreen) for bromodomain activity.
  • Mechanistic Studies: Facilitates the understanding of gene expression mechanisms and the functional consequences of bromodomain inhibition.

Basic Information

Product Name Brd2
CAS No. 1597439-91-2
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms BRD2 Inhibitor; Bromodomain-containing protein 2 inhibitor; BRD2 antagonist; (S)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate; 1597439-91-2; BRD2i; BRD2 small molecule inhibitor
EINECS Contact for details

Quality Control

Every batch of our Brd2 (1597439-91-2) is manufactured under strict quality management systems and undergoes comprehensive analytical characterization to ensure identity, purity, and batch-to-batch consistency. We provide full supporting documentation, including a detailed Certificate of Analysis (COA) with data from HPLC, NMR, and MS. Our quality commitment aligns with standards expected for preclinical research materials.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under inert atmosphere for long-term stability. Allow the product to equilibrate to room temperature in a desiccator before opening to minimize moisture uptake. Store away from strong acids and bases.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms to reference standard
Identification (MS) Conforms to structure
Purity (HPLC) ≥95%
Water Content (KF) ≤1.0%
Residual Solvents (GC) Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.